相关实验视频
Updated: Sep 16, 2025
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
环指蛋白RNF126通过调节MBNL1促进前列腺癌的进展
Xin Jiang1,2, Ji Li1, Jiali Zhang3
1Baoying People's Hospital, 1 Xincheng Road, Baoying, Yangzhou, 225800, Jiangsu Province, China.
Scientific reports
|July 4, 2025
概括
过度表达RNF126通过调节MBNL1和关键信号通路,驱动前列腺癌 (PCa) 的进展和化学抵抗. 这项研究揭示了RNF126作为PCa治疗的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 过度表达RNF126与瘤进展有关.
- 它在前列腺癌 (PCa) 中的精确机制需要进一步阐明.
研究的目的:
- 研究PCa.中RNF126的生物功能和分子机制.
- 确定RNF126表达与PCa进展和预后之间的关联.
主要方法:
- 在PCa组织和细胞系中评估RNF126表达.
- 评估了细胞增殖,迁移,上皮层-介质酶转变 (EMT) 和多塞塔克塞尔耐药性.
- 研究了RNF126点蛋白和信号通路 (PI3K/AKT,MEK/ERK).
- 在体内进行异种移植测定和MBNL1倒置救援实验.
主要成果:
- 在PCa中,RNF126的表达很高,与预后不佳相关.
- RNF126调节PCa细胞的增殖,迁移,EMT和化学抵抗.
- RNF126直接与MBNL1结合,MBNL1是RNF126驱动的瘤发生和化学抵抗的关键媒介.
- RNF126通过MBNL1.1调节PI3K/AKT,MEK/ERK和EMT通路,通过MBNL1.6调节PI3K/AKT,MEK/ERK和EMT通路.
结论:
- RNF126在PCa的进展,化学抵抗和转移中发挥着关键作用.
- RNF126-MBNL1相互作用是驱动PCa的一个关键机制.
- RNF126代表了PCa治疗的潜在治疗标.
相关概念视频
01:23Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
02:54Canonical Wnt Signaling Pathway
9.0K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K
02:23Master Transcription Regulators
7.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.1K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:26NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K